{
  "cik": 1680581,
  "cik_padded": "0001680581",
  "entityName": "Fulcrum Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-065197",
      "filed": "2026-02-24",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 314000.0,
        "cash": 197533000.0,
        "eps_diluted": -1.18,
        "free_cash_flow": -60379000.0,
        "net_income": -74880000.0,
        "operating_cash_flow": -60065000.0,
        "operating_income": -84769000.0,
        "stockholders_equity": 349000000.0,
        "total_assets": 366284000.0,
        "total_liabilities": 17284000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.0495243553008596,
        "roa_avg2y": -0.23885091275625914,
        "roa_period_end": -0.20443153400093916,
        "roe_avg2y": -0.2529584449541749,
        "roe_period_end": -0.21455587392550143
      }
    },
    {
      "accn": "0001193125-26-065197",
      "filed": "2026-02-24",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 278000.0,
        "cash": 58212000.0,
        "eps_diluted": -0.16,
        "free_cash_flow": -2496000.0,
        "net_income": -9725000.0,
        "operating_cash_flow": -2218000.0,
        "operating_income": -21897000.0,
        "stockholders_equity": 243034000.0,
        "total_assets": 260718000.0,
        "total_liabilities": 17684000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.07276348165277287,
        "roa_avg2y": -0.03751842164147435,
        "roa_period_end": -0.03730083845380833,
        "roe_avg2y": -0.04067106206885015,
        "roe_period_end": -0.04001497732827505
      }
    },
    {
      "accn": "0001193125-26-065197",
      "filed": "2026-02-24",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 508000.0,
        "cash": 25563000.0,
        "eps_diluted": -1.59,
        "free_cash_flow": -91473000.0,
        "net_income": -97335000.0,
        "operating_cash_flow": -90965000.0,
        "operating_income": -110664000.0,
        "stockholders_equity": 235193000.0,
        "total_assets": 257694000.0,
        "total_liabilities": 22501000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.09567036433907472,
        "roa_avg2y": -0.401896035955316,
        "roa_period_end": -0.37771542992851986,
        "roe_avg2y": -0.448408905064093,
        "roe_period_end": -0.4138516027262716
      }
    },
    {
      "accn": "0000950170-25-026068",
      "filed": "2025-02-25",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1963000.0,
        "cash": 35098000.0,
        "eps_diluted": -2.44,
        "free_cash_flow": -99013000.0,
        "net_income": -109871000.0,
        "operating_cash_flow": -97050000.0,
        "operating_income": -112561000.0,
        "stockholders_equity": 198942000.0,
        "total_assets": 226685000.0,
        "total_liabilities": 27743000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.13945270480843663,
        "roa_avg2y": -0.475956550461895,
        "roa_period_end": -0.4846857974722633,
        "roe_avg2y": -0.5353280663416821,
        "roe_period_end": -0.5522765429120045
      }
    },
    {
      "accn": "0000950170-24-021074",
      "filed": "2024-02-27",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1713000.0,
        "cash": 35412000.0,
        "eps_diluted": -2.29,
        "free_cash_flow": -80191000.0,
        "net_income": -80847000.0,
        "operating_cash_flow": -78478000.0,
        "operating_income": -81054000.0,
        "stockholders_equity": 211539000.0,
        "total_assets": 235000000.0,
        "total_liabilities": 23461000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1109062631476938,
        "roa_avg2y": -0.44351124728109564,
        "roa_period_end": -0.34402978723404254,
        "roe_avg2y": -0.5271713615023474,
        "roe_period_end": -0.3821848453476664
      }
    },
    {
      "accn": "0000950170-23-029693",
      "filed": "2023-06-26",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1342000.0,
        "cash": 57052000.0,
        "eps_diluted": -2.79,
        "free_cash_flow": -54997000.0,
        "net_income": -70819000.0,
        "operating_cash_flow": -53655000.0,
        "operating_income": -71611000.0,
        "stockholders_equity": 95181000.0,
        "total_assets": 129577000.0,
        "total_liabilities": 34396000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.36137464409913744,
        "roa_avg2y": -0.5901189920671955,
        "roa_period_end": -0.5465398951974502,
        "roe_avg2y": -0.776805203637281,
        "roe_period_end": -0.7440455553104086
      }
    },
    {
      "accn": "0000950170-23-029689",
      "filed": "2023-06-26",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 853000.0,
        "cash": 96713000.0,
        "free_cash_flow": -40336000.0,
        "net_income": -82677000.0,
        "operating_cash_flow": -39483000.0,
        "operating_income": -84217000.0,
        "stockholders_equity": 87153000.0,
        "total_assets": 110439000.0,
        "total_liabilities": 23286000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.2671852948263399,
        "roa_avg2y": -0.842739921512665,
        "roa_period_end": -0.7486214109146225,
        "roe_avg2y": -7.041434229016735,
        "roe_period_end": -0.9486420433031565
      }
    },
    {
      "accn": "0000950170-23-029682",
      "filed": "2023-06-23",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 8981000.0,
        "cash": 72797000.0,
        "free_cash_flow": -31543000.0,
        "net_income": -32588000.0,
        "operating_cash_flow": -22562000.0,
        "operating_income": -33498000.0,
        "stockholders_equity": -63670000.0,
        "total_assets": 85771000.0,
        "total_liabilities": 9771000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.3799419384174138,
        "roe_avg2y": 0.6723680817042348
      }
    },
    {
      "accn": "0001564590-20-008951",
      "filed": "2020-03-05",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -33265000.0
      },
      "period_end": "2017-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-065197",
    "filed": "2026-02-24",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001680581.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001680581.json"
  },
  "ticker": "FULC"
}